25 XP   0   0   10

Kunming Longjin Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Longjin together

PenkeI guess you are interested in Kunming Longjin Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Kunming Longjin Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Kunming Longjin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Kunming Longjin Pharmaceutical Co Ltd.

Quick analysis of Longjin (30 sec.)










What can you expect buying and holding a share of Longjin? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
51.3%

What is your share worth?

Current worth
¥1.45
Expected worth in 1 year
¥1.23
How sure are you?
74.4%

+ What do you gain per year?

Total Gains per Share
¥-0.22
Return On Investment
-3.7%

For what price can you sell your share?

Current Price per Share
¥5.87
Expected price per share
¥4.66 - ¥8.8
How sure are you?
50%

1. Valuation of Longjin (5 min.)




Live pricePrice per Share (EOD)

¥5.87

Intrinsic Value Per Share

¥-1.28 - ¥-1.49

Total Value Per Share

¥0.17 - ¥-0.04

2. Growth of Longjin (5 min.)




Is Longjin growing?

Current yearPrevious yearGrowGrow %
How rich?$80.3m$93.2m-$11.2m-13.7%

How much money is Longjin making?

Current yearPrevious yearGrowGrow %
Making money-$2.7m-$234.6k-$2.5m-91.4%
Net Profit Margin-93.4%-3.9%--

How much money comes from the company's main activities?

3. Financial Health of Longjin (5 min.)




What can you expect buying and holding a share of Longjin? (5 min.)

Welcome investor! Longjin's management wants to use your money to grow the business. In return you get a share of Longjin.

What can you expect buying and holding a share of Longjin?

First you should know what it really means to hold a share of Longjin. And how you can make/lose money.

Speculation

The Price per Share of Longjin is ¥5.87. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Longjin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Longjin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.45. Based on the TTM, the Book Value Change Per Share is ¥-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Longjin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.00-0.1%-0.01-0.1%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.00-0.1%-0.01-0.1%0.00-0.1%0.000.0%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.1%
Usd Total Gains Per Share0.00-0.1%-0.01-0.1%0.00-0.1%0.000.0%0.010.2%
Usd Price Per Share1.47-1.44-1.90-1.48-2.07-
Price to Earnings Ratio-98.05--94.95-9.43-151.11-153.86-
Price-to-Total Gains Ratio-391.93--628.30-1,933.99-855.13-1,012.41-
Price to Book Ratio7.32-7.03-8.13-6.48-9.60-
Price-to-Total Gains Ratio-391.93--628.30-1,933.99-855.13-1,012.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.810647
Number of shares1233
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (1233 shares)-9.32-1.39
Gains per Year (1233 shares)-37.29-5.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-37-470-6-16
20-75-840-11-22
30-112-1210-17-28
40-149-1580-22-34
50-186-1950-28-40
60-224-2320-34-46
70-261-2690-39-52
80-298-3060-45-58
90-336-3430-50-64
100-373-3800-56-70

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%5.07.00.041.7%9.011.00.045.0%28.011.00.071.8%28.011.00.071.8%
Book Value Change Per Share0.04.00.00.0%5.07.00.041.7%11.09.00.055.0%25.013.01.064.1%25.013.01.064.1%
Dividend per Share0.00.04.00.0%4.00.08.033.3%5.00.015.025.0%20.00.019.051.3%20.00.019.051.3%
Total Gains per Share0.04.00.00.0%5.07.00.041.7%11.09.00.055.0%29.09.01.074.4%29.09.01.074.4%

Fundamentals of Longjin

About Kunming Longjin Pharmaceutical Co Ltd

Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business. Kunming Longjin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Kunming, China.

Fundamental data was last updated by Penke on 2024-04-14 19:21:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Kunming Longjin Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Longjin earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Longjin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -39.6% means that ¥-0.40 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is -39.6%. The company is making a huge loss. -2
  • The TTM is -93.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-39.6%TTM-93.4%+53.8%
TTM-93.4%YOY-3.9%-89.5%
TTM-93.4%5Y-20.1%-73.3%
5Y-20.1%10Y2.6%-22.7%
1.1.2. Return on Assets

Shows how efficient Longjin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Longjin to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.6% Return on Assets means that Longjin generated ¥-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is -1.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.6%TTM-2.7%+1.1%
TTM-2.7%YOY-0.2%-2.5%
TTM-2.7%5Y-0.6%-2.1%
5Y-0.6%10Y0.7%-1.3%
1.1.3. Return on Equity

Shows how efficient Longjin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Longjin to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.0% Return on Equity means Longjin generated ¥-0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is -2.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-3.4%+1.5%
TTM-3.4%YOY-0.3%-3.2%
TTM-3.4%5Y-0.8%-2.7%
5Y-0.8%10Y1.0%-1.8%

1.2. Operating Efficiency of Kunming Longjin Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Longjin is operating .

  • Measures how much profit Longjin makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Longjin to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -58.6% means the company generated ¥-0.59  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is -58.6%. The company is operating very inefficient. -2
  • The TTM is -73.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-58.6%TTM-73.6%+14.9%
TTM-73.6%YOY-15.0%-58.6%
TTM-73.6%5Y-18.3%-55.2%
5Y-18.3%10Y-9.5%-8.8%
1.2.2. Operating Ratio

Measures how efficient Longjin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.87 means that the operating costs are ¥1.87 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is 1.875. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.957. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.875TTM1.957-0.083
TTM1.957YOY1.405+0.553
TTM1.9575Y1.459+0.498
5Y1.45910Y0.897+0.563

1.3. Liquidity of Kunming Longjin Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Longjin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 6.84 means the company has ¥6.84 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is 6.844. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.874. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.844TTM6.874-0.031
TTM6.874YOY4.980+1.894
TTM6.8745Y5.176+1.698
5Y5.17610Y2.895+2.282
1.3.2. Quick Ratio

Measures if Longjin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Longjin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 4.69 means the company can pay off ¥4.69 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is 4.693. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.200. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.693TTM4.200+0.493
TTM4.200YOY3.635+0.565
TTM4.2005Y2.764+1.436
5Y2.76410Y1.582+1.182

1.4. Solvency of Kunming Longjin Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Longjin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Longjin to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.15 means that Longjin assets are financed with 14.8% credit (debt) and the remaining percentage (100% - 14.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is 0.148. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.155. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.148TTM0.155-0.007
TTM0.155YOY0.170-0.015
TTM0.1555Y0.179-0.025
5Y0.17910Y0.176+0.003
1.4.2. Debt to Equity Ratio

Measures if Longjin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Longjin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 18.1% means that company has ¥0.18 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The MRQ is 0.181. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.191. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.181TTM0.191-0.010
TTM0.191YOY0.216-0.025
TTM0.1915Y0.240-0.049
5Y0.24010Y0.234+0.006

2. Market Valuation of Kunming Longjin Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Longjin generates.

  • Above 15 is considered overpriced but always compare Longjin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -98.05 means the investor is paying ¥-98.05 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The EOD is -54.096. Based on the earnings, the company is expensive. -2
  • The MRQ is -98.054. Based on the earnings, the company is expensive. -2
  • The TTM is -94.946. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-54.096MRQ-98.054+43.959
MRQ-98.054TTM-94.946-3.108
TTM-94.946YOY9.434-104.380
TTM-94.9465Y151.106-246.052
5Y151.10610Y153.860-2.754
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The EOD is -66.103. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -119.818. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -125.148. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-66.103MRQ-119.818+53.716
MRQ-119.818TTM-125.148+5.329
TTM-125.148YOY53.362-178.510
TTM-125.1485Y118.465-243.613
5Y118.46510Y265.400-146.935
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Longjin is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Kunming Longjin Pharmaceutical Co Ltd:

  • The EOD is 4.038. Based on the equity, the company is fair priced.
  • The MRQ is 7.320. Based on the equity, the company is overpriced. -1
  • The TTM is 7.032. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.038MRQ7.320-3.282
MRQ7.320TTM7.032+0.288
TTM7.032YOY8.130-1.098
TTM7.0325Y6.478+0.554
5Y6.47810Y9.603-3.125
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Kunming Longjin Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.027-0.055+102%-0.032+18%-0.008-70%0.037-173%
Book Value Per Share--1.4541.483-2%1.686-14%1.660-12%1.508-4%
Current Ratio--6.8446.8740%4.980+37%5.176+32%2.895+136%
Debt To Asset Ratio--0.1480.155-4%0.170-13%0.179-17%0.176-16%
Debt To Equity Ratio--0.1810.191-5%0.216-16%0.240-25%0.234-23%
Dividend Per Share----0%-0%0.000-100%0.041-100%
Eps---0.027-0.049+82%-0.004-84%-0.011-58%0.011-342%
Free Cash Flow Per Share---0.022-0.040+81%-0.020-10%-0.018-20%0.021-204%
Free Cash Flow To Equity Per Share---0.014-0.046+219%-0.027+88%-0.001-93%0.092-116%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.490--------
Intrinsic Value_10Y_min---1.279--------
Intrinsic Value_1Y_max---0.121--------
Intrinsic Value_1Y_min---0.119--------
Intrinsic Value_3Y_max---0.385--------
Intrinsic Value_3Y_min---0.367--------
Intrinsic Value_5Y_max---0.675--------
Intrinsic Value_5Y_min---0.624--------
Market Cap2350935000.000-81%4261320000.0004176213750.000+2%5495861250.000-22%4284934968.750-1%5999482548.077-29%
Net Profit Margin---0.396-0.934+136%-0.039-90%-0.201-49%0.026-1603%
Operating Margin---0.586-0.736+26%-0.150-74%-0.183-69%-0.095-84%
Operating Ratio--1.8751.957-4%1.405+33%1.459+28%0.897+109%
Pb Ratio4.038-81%7.3207.032+4%8.130-10%6.478+13%9.603-24%
Pe Ratio-54.096+45%-98.054-94.946-3%9.434-1139%151.106-165%153.860-164%
Price Per Share5.870-81%10.64010.428+2%13.723-22%10.6920%14.976-29%
Price To Free Cash Flow Ratio-66.103+45%-119.818-125.148+4%53.362-325%118.465-201%265.400-145%
Price To Total Gains Ratio-216.226+45%-391.933-628.299+60%1933.988-120%855.131-146%1012.412-139%
Quick Ratio--4.6934.200+12%3.635+29%2.764+70%1.582+197%
Return On Assets---0.016-0.027+72%-0.002-87%-0.006-60%0.007-323%
Return On Equity---0.020-0.034+76%-0.003-86%-0.008-60%0.010-291%
Total Gains Per Share---0.027-0.055+102%-0.032+18%-0.008-70%0.078-135%
Usd Book Value--80395788.62882007296.516-2%93250322.712-14%91923929.730-13%83441179.318-4%
Usd Book Value Change Per Share---0.004-0.008+102%-0.004+18%-0.001-70%0.005-173%
Usd Book Value Per Share--0.2010.205-2%0.233-14%0.229-12%0.208-4%
Usd Dividend Per Share----0%-0%0.000-100%0.006-100%
Usd Eps---0.004-0.007+82%-0.001-84%-0.002-58%0.002-342%
Usd Free Cash Flow---1227876.914-2227932.440+81%-1110484.029-10%-977920.663-20%1150297.259-207%
Usd Free Cash Flow Per Share---0.003-0.006+81%-0.003-10%-0.002-20%0.003-204%
Usd Free Cash Flow To Equity Per Share---0.002-0.006+219%-0.004+88%0.000-93%0.013-116%
Usd Market Cap324664123.500-81%588488292.000576735118.875+2%758978438.625-22%591749519.184-1%828528539.889-29%
Usd Price Per Share0.811-81%1.4691.440+2%1.895-22%1.4760%2.068-29%
Usd Profit---1500415.071-2742725.302+83%-234649.297-84%-632601.787-58%617827.132-343%
Usd Revenue--3786615.7793150056.629+20%7301647.968-48%10427351.705-64%9415196.987-60%
Usd Total Gains Per Share---0.004-0.008+102%-0.004+18%-0.001-70%0.011-135%
 EOD+3 -5MRQTTM+26 -7YOY+14 -195Y+7 -2810Y+8 -27

3.2. Fundamental Score

Let's check the fundamental score of Kunming Longjin Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-54.096
Price to Book Ratio (EOD)Between0-14.038
Net Profit Margin (MRQ)Greater than0-0.396
Operating Margin (MRQ)Greater than0-0.586
Quick Ratio (MRQ)Greater than14.693
Current Ratio (MRQ)Greater than16.844
Debt to Asset Ratio (MRQ)Less than10.148
Debt to Equity Ratio (MRQ)Less than10.181
Return on Equity (MRQ)Greater than0.15-0.020
Return on Assets (MRQ)Greater than0.05-0.016
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Kunming Longjin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.018
Ma 20Greater thanMa 506.492
Ma 50Greater thanMa 1006.902
Ma 100Greater thanMa 2008.269
OpenGreater thanClose5.620
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets683,057
Total Liabilities100,901
Total Stockholder Equity556,388
 As reported
Total Liabilities 100,901
Total Stockholder Equity+ 556,388
Total Assets = 683,057

Assets

Total Assets683,057
Total Current Assets411,557
Long-term Assets271,500
Total Current Assets
Cash And Cash Equivalents 93,232
Short-term Investments 253,518
Net Receivables 28,706
Inventory 31,245
Other Current Assets 4,856
Total Current Assets  (as reported)411,557
Total Current Assets  (calculated)411,557
+/- 0
Long-term Assets
Property Plant Equipment 184,246
Goodwill 10,087
Intangible Assets 67,078
Long-term Assets Other 1,438
Long-term Assets  (as reported)271,500
Long-term Assets  (calculated)262,849
+/- 8,651

Liabilities & Shareholders' Equity

Total Current Liabilities60,137
Long-term Liabilities40,764
Total Stockholder Equity556,388
Total Current Liabilities
Accounts payable 10,864
Other Current Liabilities 38,937
Total Current Liabilities  (as reported)60,137
Total Current Liabilities  (calculated)49,800
+/- 10,336
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,030
Other Liabilities 39,735
Long-term Liabilities  (as reported)40,764
Long-term Liabilities  (calculated)40,764
+/- 0
Total Stockholder Equity
Common Stock400,500
Retained Earnings 155,775
Total Stockholder Equity (as reported)556,388
Total Stockholder Equity (calculated)556,275
+/- 113
Other
Capital Stock400,500
Common Stock Shares Outstanding 400,500
Net Invested Capital 556,388
Net Tangible Assets 497,075
Net Working Capital 351,421
Property Plant and Equipment Gross 184,246



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-31
> Total Assets 
287,365
368,054
442,563
0
407,398
420,247
435,588
712,739
667,248
667,922
698,859
723,314
712,136
718,006
759,680
772,281
742,604
775,112
785,229
798,420
771,038
767,959
787,550
770,550
774,982
790,492
806,892
800,504
794,911
825,187
841,756
993,723
1,030,885
1,045,633
827,280
817,236
805,169
803,011
747,205
685,871
695,788
683,057
683,057695,788685,871747,205803,011805,169817,236827,2801,045,6331,030,885993,723841,756825,187794,911800,504806,892790,492774,982770,550787,550767,959771,038798,420785,229775,112742,604772,281759,680718,006712,136723,314698,859667,922667,248712,739435,588420,247407,3980442,563368,054287,365
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
458,983
462,104
472,570
462,062
455,682
451,734
479,482
479,109
473,795
500,563
519,611
672,102
709,798
733,186
522,767
518,064
510,420
503,804
471,036
413,149
414,559
411,557
411,557414,559413,149471,036503,804510,420518,064522,767733,186709,798672,102519,611500,563473,795479,109479,482451,734455,682462,062472,570462,104458,98300000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,714
32,300
384,284
354,782
385,288
369,146
195,429
90,903
54,885
176,667
123,977
131,569
112,535
109,259
102,039
87,289
116,622
80,270
191,072
143,554
98,732
93,232
93,23298,732143,554191,07280,270116,62287,289102,039109,259112,535131,569123,977176,66754,88590,903195,429369,146385,288354,782384,28432,30028,71400000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
350,000
0
10,000
30,000
0
20,000
208,303
313,787
353,734
250,212
287,610
259,422
304,698
317,546
327,453
332,414
292,651
335,568
213,275
213,391
252,302
253,518
253,518252,302213,391213,275335,568292,651332,414327,453317,546304,698259,422287,610250,212353,734313,787208,30320,000030,00010,0000350,00000000000000000000000
       Net Receivables 
15,080
4,279
3,794
0
1,810
1,724
2,735
2,906
3,779
6,052
6,520
4,137
4,779
1,405
7,912
12,126
16,464
32,059
48,234
47,385
42,434
38,964
42,951
33,713
32,032
25,904
38,680
34,426
29,043
31,296
50,968
140,269
148,780
141,466
55,934
59,579
56,925
40,526
37,942
15,156
25,482
28,706
28,70625,48215,15637,94240,52656,92559,57955,934141,466148,780140,26950,96831,29629,04334,42638,68025,90432,03233,71342,95138,96442,43447,38548,23432,05916,46412,1267,9121,4054,7794,1376,5206,0523,7792,9062,7351,7241,81003,7944,27915,080
       Inventory 
7,365
10,450
12,042
0
10,241
15,189
16,189
20,070
19,035
18,442
18,239
16,665
14,487
14,901
23,051
24,931
28,909
29,998
29,870
30,314
31,413
29,540
27,185
29,560
28,714
28,455
35,716
37,031
33,315
31,529
54,671
120,101
131,684
137,521
32,905
35,721
42,305
46,133
27,779
30,510
32,789
31,245
31,24532,78930,51027,77946,13342,30535,72132,905137,521131,684120,10154,67131,52933,31537,03135,71628,45528,71429,56027,18529,54031,41330,31429,87029,99828,90924,93123,05114,90114,48716,66518,23918,44219,03520,07016,18915,18910,241012,04210,4507,365
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
308,487
319,300
338,758
327,410
321,395
321,116
324,625
322,145
321,621
321,087
312,447
304,513
299,173
294,749
299,207
276,169
272,722
281,229
271,500
271,500281,229272,722276,169299,207294,749299,173304,513312,447321,087321,621322,145324,625321,116321,395327,410338,758319,300308,48700000000000000000000000
       Property Plant Equipment 
139,830
217,687
299,181
0
289,753
284,502
279,079
273,776
269,117
264,613
261,607
256,865
253,758
248,477
247,657
243,024
237,962
239,460
245,653
242,133
237,516
232,918
230,521
227,182
222,204
218,169
242,359
238,223
234,827
242,359
239,526
239,685
234,375
228,257
223,254
219,974
213,799
208,617
202,478
196,839
190,663
184,246
184,246190,663196,839202,478208,617213,799219,974223,254228,257234,375239,685239,526242,359234,827238,223242,359218,169222,204227,182230,521232,918237,516242,133245,653239,460237,962243,024247,657248,477253,758256,865261,607264,613269,117273,776279,079284,502289,7530299,181217,687139,830
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,051
2,051
2,053
2,053
2,053
2,053
2,053
2,053
2,053
2,053
1,897
1,897
1,897
1,897
0
0
10,087
10,087
10,08710,087001,8971,8971,8971,8972,0532,0532,0532,0532,0532,0532,0532,0532,0512,051000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,566
24,683
23,700
22,708
24,553
24,457
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000024,45724,55322,70823,70024,68325,56600000000000000000000
       Intangible Assets 
21,384
20,872
20,359
0
20,103
19,975
19,847
19,808
19,675
19,543
19,414
19,285
19,156
19,027
18,897
18,768
18,639
18,510
18,381
18,252
18,122
17,993
26,272
34,296
29,493
45,254
50,118
49,273
48,676
47,660
46,701
45,606
48,989
48,071
47,183
46,676
46,323
47,491
44,994
50,784
66,499
67,078
67,07866,49950,78444,99447,49146,32346,67647,18348,07148,98945,60646,70147,66048,67649,27350,11845,25429,49334,29626,27217,99318,12218,25218,38118,51018,63918,76818,89719,02719,15619,28519,41419,54319,67519,80819,84719,97520,103020,35920,87221,384
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,842
17,935
41,421
2,370
1,632
6,048
245,017
3,847
2,841
3,691
2,898
4,387
3,545
7,471
16,446
17,631
14,900
5,173
1,438
1,4385,17314,90017,63116,4467,4713,5454,3872,8983,6912,8413,847245,0176,0481,6322,37041,42117,93515,84200000000000000000000000
> Total Liabilities 
100,624
141,113
140,566
0
158,863
154,989
150,018
110,328
100,530
86,260
99,451
107,896
98,945
65,078
89,224
87,938
108,882
134,084
139,689
145,637
126,590
119,910
131,617
109,406
107,686
104,287
141,003
130,723
124,285
131,471
137,050
274,420
310,440
324,269
148,986
138,253
131,351
133,156
142,440
90,520
102,759
100,901
100,901102,75990,520142,440133,156131,351138,253148,986324,269310,440274,420137,050131,471124,285130,723141,003104,287107,686109,406131,617119,910126,590145,637139,689134,084108,88287,93889,22465,07898,945107,89699,45186,260100,530110,328150,018154,989158,8630140,566141,113100,624
   > Total Current Liabilities 
90,124
129,130
119,939
0
138,862
129,175
125,077
85,817
77,149
63,209
70,051
78,902
70,355
36,894
61,534
60,653
82,003
105,610
111,886
118,240
101,598
95,323
99,435
77,629
76,315
73,321
105,251
95,428
89,444
96,776
100,284
235,389
271,479
285,439
113,396
102,804
97,741
99,774
87,657
48,475
61,354
60,137
60,13761,35448,47587,65799,77497,741102,804113,396285,439271,479235,389100,28496,77689,44495,428105,25173,32176,31577,62999,43595,323101,598118,240111,886105,61082,00360,65361,53436,89470,35578,90270,05163,20977,14985,817125,077129,175138,8620119,939129,13090,124
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,128
10,014
0
0
0
0
0
0
0
0
0000000010,01410,12800000000000000000000000000000000
       Accounts payable 
14,910
16,976
45,027
0
33,801
27,537
25,582
17,560
9,825
7,703
8,700
5,277
5,918
2,334
5,815
3,894
4,937
3,769
6,782
4,677
5,902
6,579
14,982
14,323
8,228
9,801
13,990
13,194
8,275
12,250
15,277
138,656
162,422
176,361
11,825
12,844
14,634
12,030
10,103
10,386
13,052
10,864
10,86413,05210,38610,10312,03014,63412,84411,825176,361162,422138,65615,27712,2508,27513,19413,9909,8018,22814,32314,9826,5795,9024,6776,7823,7694,9373,8945,8152,3345,9185,2778,7007,7039,82517,56025,58227,53733,801045,02716,97614,910
       Other Current Liabilities 
55,214
112,154
74,912
0
75,060
71,638
69,495
68,256
67,324
55,507
61,350
73,624
64,437
34,560
55,719
56,759
77,066
101,841
105,103
113,563
17,899
83,455
16,198
57,442
21,313
57,537
40,560
75,503
38,342
77,623
38,485
87,285
49,030
89,647
93,388
81,421
39,168
78,900
38,768
905
21,436
38,937
38,93721,43690538,76878,90039,16881,42193,38889,64749,03087,28538,48577,62338,34275,50340,56057,53721,31357,44216,19883,45517,899113,563105,103101,84177,06656,75955,71934,56064,43773,62461,35055,50767,32468,25669,49571,63875,060074,912112,15455,214
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,777
31,371
30,966
35,752
35,295
34,841
34,694
36,766
39,032
38,962
38,830
35,589
35,449
33,611
33,382
54,783
42,045
41,405
40,764
40,76441,40542,04554,78333,38233,61135,44935,58938,83038,96239,03236,76634,69434,84135,29535,75230,96631,37131,77700000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,945
2,981
3,017
1,155
1,170
1,187
1,205
984
999
1,014
1,030
1,0301,0149999841,2051,1871,1701,1553,0172,9812,9450000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,298
0
0
0
00012,29800000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,528
3,588
4,753
10,199
14,193
13,585
15,106
15,610
15,875
16,222
16,494
16,899
21,356
21,526
17,399
17,332
17,351
19,024
16,930
0
17,040
18,587
18,58717,040016,93019,02417,35117,33217,39921,52621,35616,89916,49416,22215,87515,61015,10613,58514,19310,1994,7533,5883,52800000000000000000000
> Total Stockholder Equity
186,741
226,941
301,997
301,997
248,535
265,258
285,570
602,411
566,718
581,662
599,446
615,456
613,229
652,928
670,456
684,403
633,783
641,090
645,540
652,782
644,448
648,049
647,395
652,633
648,735
649,201
624,242
620,053
622,636
626,527
636,054
638,690
640,927
642,626
639,147
639,979
636,680
635,830
583,031
574,913
567,253
556,388
556,388567,253574,913583,031635,830636,680639,979639,147642,626640,927638,690636,054626,527622,636620,053624,242649,201648,735652,633647,395648,049644,448652,782645,540641,090633,783684,403670,456652,928613,229615,456599,446581,662566,718602,411285,570265,258248,535301,997301,997226,941186,741
   Common Stock
50,000
50,000
50,000
0
50,000
50,000
50,000
66,750
66,750
200,250
200,250
200,250
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
400,500
0
400,500
400,500
400,500400,5000400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500400,500200,250200,250200,25066,75066,75050,00050,00050,000050,00050,00050,000
   Retained Earnings 
109,338
143,514
218,570
0
194,115
210,837
231,150
245,853
210,160
225,104
242,889
258,898
212,617
252,315
269,843
283,790
233,170
240,477
244,927
252,170
243,835
247,436
246,783
204,641
200,744
201,210
223,629
219,440
222,023
225,914
235,441
238,077
240,314
242,014
238,534
239,367
236,068
235,217
182,418
123,219
166,640
155,775
155,775166,640123,219182,418235,217236,068239,367238,534242,014240,314238,077235,441225,914222,023219,440223,629201,210200,744204,641246,783247,436243,835252,170244,927240,477233,170283,790269,843252,315212,617258,898242,889225,104210,160245,853231,150210,837194,1150218,570143,514109,338
   Capital Surplus 000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue91,240
Cost of Revenue-29,511
Gross Profit61,72961,729
 
Operating Income (+$)
Gross Profit61,729
Operating Expense-147,926
Operating Income-56,686-86,197
 
Operating Expense (+$)
Research Development22,583
Selling General Administrative76,617
Selling And Marketing Expenses-
Operating Expense147,92699,200
 
Net Interest Income (+$)
Interest Income395
Interest Expense--
Other Finance Cost-681
Net Interest Income1,076
 
Pretax Income (+$)
Operating Income-56,686
Net Interest Income1,076
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-94,044-56,686
EBIT - interestExpense = 0
-79,442
-79,442
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--94,044
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-94,044
Tax Provision-3,441
Net Income From Continuing Ops-97,485-97,485
Net Income-79,442
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--1,076
 

Technical Analysis of Longjin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Longjin. The general trend of Longjin is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Longjin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Kunming Longjin Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.35 < 7.88 < 8.8.

The bearish price targets are: 4.66.

Tweet this
Kunming Longjin Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Kunming Longjin Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Kunming Longjin Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Kunming Longjin Pharmaceutical Co Ltd. The current macd is -0.45838274.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Longjin price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Longjin. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Longjin price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Kunming Longjin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartKunming Longjin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Kunming Longjin Pharmaceutical Co Ltd. The current adx is 21.64.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Longjin shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Kunming Longjin Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Kunming Longjin Pharmaceutical Co Ltd. The current sar is 6.09621852.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Kunming Longjin Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Kunming Longjin Pharmaceutical Co Ltd. The current rsi is 39.02. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Kunming Longjin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartKunming Longjin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Kunming Longjin Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Longjin price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Kunming Longjin Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartKunming Longjin Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Kunming Longjin Pharmaceutical Co Ltd. The current cci is -68.07539448.

Kunming Longjin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartKunming Longjin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Kunming Longjin Pharmaceutical Co Ltd. The current cmo is -23.110476.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Kunming Longjin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartKunming Longjin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Kunming Longjin Pharmaceutical Co Ltd. The current willr is -86.26609442.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Kunming Longjin Pharmaceutical Co Ltd Daily Williams %R ChartKunming Longjin Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Kunming Longjin Pharmaceutical Co Ltd.

Kunming Longjin Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Kunming Longjin Pharmaceutical Co Ltd. The current atr is 0.41728909.

Kunming Longjin Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartKunming Longjin Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Kunming Longjin Pharmaceutical Co Ltd. The current obv is 571,705,927.

Kunming Longjin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartKunming Longjin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Kunming Longjin Pharmaceutical Co Ltd. The current mfi is 42.28.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Kunming Longjin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartKunming Longjin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Kunming Longjin Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Kunming Longjin Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Kunming Longjin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.018
Ma 20Greater thanMa 506.492
Ma 50Greater thanMa 1006.902
Ma 100Greater thanMa 2008.269
OpenGreater thanClose5.620
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Longjin with someone you think should read this too:
  • Are you bullish or bearish on Longjin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Longjin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Kunming Longjin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Kunming Longjin Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Kunming Longjin Pharmaceutical Co Ltd.

Receive notifications about Kunming Longjin Pharmaceutical Co Ltd in your mailbox!